Youli Lu

445 total citations
23 papers, 335 citations indexed

About

Youli Lu is a scholar working on Molecular Biology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Youli Lu has authored 23 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Youli Lu's work include Metabolism and Genetic Disorders (4 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Analytical Methods in Pharmaceuticals (4 papers). Youli Lu is often cited by papers focused on Metabolism and Genetic Disorders (4 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Analytical Methods in Pharmaceuticals (4 papers). Youli Lu collaborates with scholars based in China and Australia. Youli Lu's co-authors include Yiping Wang, Li‐Jiang Xuan, Xiaochuan Li, Chen Yu, Yanling Ma, Jie Zhang, Wenyu Wu, Hong Yan, Wenyi Wang and Gangyi Liu and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Diabetes Care.

In The Last Decade

Youli Lu

23 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youli Lu China 11 136 84 48 40 39 23 335
Weiliang Weng China 8 143 1.1× 121 1.4× 36 0.8× 28 0.7× 76 1.9× 23 419
Qingyu Zhang China 13 198 1.5× 47 0.6× 45 0.9× 34 0.8× 54 1.4× 27 454
Longru Sun China 11 192 1.4× 125 1.5× 40 0.8× 20 0.5× 46 1.2× 22 440
Zhixin Jia China 15 246 1.8× 92 1.1× 29 0.6× 19 0.5× 70 1.8× 40 486
Xiaoquan Liu China 13 137 1.0× 95 1.1× 21 0.4× 57 1.4× 104 2.7× 50 498
Neng Fisheri Kurniati Indonesia 11 167 1.2× 39 0.5× 54 1.1× 52 1.3× 29 0.7× 67 482
Zhu-Jun Mao China 15 251 1.8× 52 0.6× 32 0.7× 50 1.3× 56 1.4× 39 554
Yanjiao Xu China 15 147 1.1× 65 0.8× 32 0.7× 31 0.8× 114 2.9× 35 481

Countries citing papers authored by Youli Lu

Since Specialization
Citations

This map shows the geographic impact of Youli Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youli Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youli Lu more than expected).

Fields of papers citing papers by Youli Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youli Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youli Lu. The network helps show where Youli Lu may publish in the future.

Co-authorship network of co-authors of Youli Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Youli Lu. A scholar is included among the top collaborators of Youli Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youli Lu. Youli Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Juan, Jun He, Youli Lu, et al.. (2024). Hepatitis B Virus Increases SphK1–S1P Synthesis by Promoting the Availability of the Transcription Factor USF1. The Journal of Immunology. 213(10). 1499–1507. 2 indexed citations
2.
Gu, Yuting, Fan Yu, Yan Liang, et al.. (2024). A novel automated multi-cycle magnetic solid-phase extraction coupled to LC-MS/MS to study the disorders of six functional B vitamins in patients with gastroenterology and hyperhomocysteinemia. Journal of Pharmaceutical and Biomedical Analysis. 241. 115989–115989. 8 indexed citations
3.
Lu, Youli, et al.. (2024). Superlong Metal–Organic Framework Micro-/Nanofibers for Selective Vitamin Absorption. Langmuir. 2 indexed citations
4.
5.
Zhang, Hongmei, Xiaoyong Li, Yixin Niu, et al.. (2022). Fasting serum fructose is associated with risk of gestational diabetes mellitus. BMC Pregnancy and Childbirth. 22(1). 446–446. 4 indexed citations
6.
Chen, Qi, Wei Wang, Mingfeng Xia, et al.. (2021). Identification of circulating sphingosine kinase-related metabolites for prediction of type 2 diabetes. Journal of Translational Medicine. 19(1). 393–393. 11 indexed citations
7.
8.
Li, Huihui, Jun Li, Xianjing Zhang, et al.. (2019). 23,24-Dihydrocucurbitacin B promotes lipid clearance by dual transcriptional regulation of LDLR and PCSK9. Acta Pharmacologica Sinica. 41(3). 327–335. 16 indexed citations
9.
Lu, Youli, Can Xiao, Jianmin Zhu, et al.. (2018). Application of a micro plasma collection card for the detection of homocysteine by liquid chromatography with tandem mass spectrometry. Journal of Separation Science. 41(22). 4167–4176. 12 indexed citations
10.
Lu, Youli, Shuijun Li, Gangyi Liu, et al.. (2016). Oral Bioavailability and Mass Balance Studies of a Novel Anti-arrhythmic Agent Sulcardine Sulfate in Sprague–Dawley Rats and Beagle Dogs. European Journal of Drug Metabolism and Pharmacokinetics. 42(3). 453–459. 1 indexed citations
11.
Huang, Jie, Qi Pei, Hongyi Tan, et al.. (2015). Pharmacokinetics of trantinterol and its metabolite in healthy elderly and young subjects. International Journal of Clinical Pharmacology and Therapeutics. 53(10). 875–882. 1 indexed citations
12.
Jia, Jingying, Gangyi Liu, Mengqi Zhang, et al.. (2015). Determination of the novel antiarrhythmic drug sulcardine sulfate in human plasma by liquid chromatography tandem mass spectrometry and its application in a clinical pharmacokinetic study. Biomedical Chromatography. 30(8). 1291–1296. 2 indexed citations
13.
Jia, Jingying, Lunan Zhang, Youli Lu, et al.. (2013). Hair analysis, a reliable and non-invasive method to evaluate the contamination by clenbuterol. Ecotoxicology and Environmental Safety. 93. 186–190. 14 indexed citations
14.
Ma, Yanling, Wenyi Wang, Jie Zhang, et al.. (2012). Hyperlipidemia and Atherosclerotic Lesion Development in Ldlr-Deficient Mice on a Long-Term High-Fat Diet. PLoS ONE. 7(4). e35835–e35835. 89 indexed citations
15.
Lu, Youli, Yanling Ma, Miaomiao Hu, et al.. (2011). Contribution of Carboxylesterase in Hamster to the Intestinal First-Pass Loss and Low Bioavailability of Ethyl Piperate, an Effective Lipid-Lowering Drug Candidate. Drug Metabolism and Disposition. 39(5). 796–802. 3 indexed citations
16.
Jia, Jingying, Youli Lu, Xiaochuan Li, et al.. (2010). Pharmacokinetics of depside salts from Salvia miltiorrhiza in healthy Chinese volunteers: A randomized, open-label, single-dose study. Current Therapeutic Research. 71(4). 260–271. 20 indexed citations
17.
Ding, Yang, Chen Yu, Shuijun Li, et al.. (2009). Liquid chromatography/tandem mass spectrometry for the determination of changrolin in rat plasma: Application to a bioavailability study. Journal of Pharmaceutical and Biomedical Analysis. 50(2). 189–193. 3 indexed citations
18.
Li, Xiaochuan, Chen Yu, Li Wang, et al.. (2007). Simultaneous determination of lithospermic acid B and its three metabolites by liquid chromatography/tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 43(5). 1864–1868. 11 indexed citations
19.
Wang, Li, Qiang Zhang, Xiaochuan Li, et al.. (2007). Pharmacokinetics and metabolism of lithospermic acid by LC/MS/MS in rats. International Journal of Pharmaceutics. 350(1-2). 240–246. 30 indexed citations
20.
Li, Xiaochuan, Chen Yu, Youli Lu, et al.. (2006). Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Depside Salts from Salvia miltiorrhiza in Rats. Drug Metabolism and Disposition. 35(2). 234–239. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weiliang Weng Breakdown of academic impact, for papers by Qingyu Zhang Breakdown of academic impact, for papers by Longru Sun Breakdown of academic impact, for papers by Zhixin Jia Breakdown of academic impact, for papers by Xiaoquan Liu Breakdown of academic impact, for papers by Neng Fisheri Kurniati Breakdown of academic impact, for papers by Zhu-Jun Mao Breakdown of academic impact, for papers by Yanjiao Xu
Rankless by CCL
2026